Nathan Moore

Title: Nathan Moore - Innovator in Pharmaceutical Combinations

Introduction

Nathan Moore is a notable inventor based in Providence, RI (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative combinations for cancer treatment. His work focuses on enhancing therapeutic options for patients suffering from various forms of cancer.

Latest Patents

Nathan Moore holds a patent for "Pharmaceutical combinations comprising a histone deacetylase inhibitor and a BCL-2 inhibitor and methods of use thereof." This patent describes a pharmaceutical combination that includes a histone deacetylase 6 inhibitor and a BCL-2 inhibitor. The disclosure emphasizes the uses of this combination in the treatment or prevention of cancer, along with methods for administering a therapeutically effective amount of the combination to subjects.

Career Highlights

Nathan Moore is currently associated with Acetylon Pharmaceuticals, Inc., where he continues to advance his research and development efforts. His work has the potential to significantly impact cancer therapies, providing new avenues for treatment and improving patient outcomes.

Collaborations

Nathan collaborates with various professionals in the field, including his coworker Chengyin Min. Their combined expertise contributes to the innovative research being conducted at Acetylon Pharmaceuticals.

Conclusion

Nathan Moore's contributions to pharmaceutical innovations, particularly in cancer treatment, highlight his role as a key inventor in the industry. His patent work and collaborations reflect a commitment to improving therapeutic options for patients.